Enhancing Efficacy and Quality of Life in Patients with Herpes Zoster Infection in Hairy Cell Leukemia

Figure 5

(a–f): Pictures of the patient after treatment: (a, b) 8 days of treatment; (c, d) 13 days of treatment; (e, f) 3 months follow-up.